Pharmaceuticals News and Research

RSS

Newron announces successful completion of patient enrollment in STARS study

Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced the successful completion of patient enrollment in its STARS clinical study.

1 Feb 2019

Insilico to present its latest results in AI for Drug Discovery on CXOTalk Show

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery on a live episode of the influential CXOTalk Show on February 8, 2019 at 1:00 PM Eastern time.

1 Feb 2019

Podcast: KHN’s ‘What the Health?’ Live from D.C.: A look ahead at health policy in 2019

The 2020 presidential campaign has begun and health is a big part of it, with Democratic candidates pledging their support for "Medicare-for-all" and many of its variations.

31 Jan 2019

Expediting HPLC Method Development in Pharmaceutical Analysis

In this interview, Michael Dong discusses stability-indicating methods such as UHPLC, in pharmaceutical analysis. At Pittcon, Michael will introduce a 3-pronged template approach to HPLC method development.

From Pittcon 30 Jan 2019

Congress wades into emotional debate over high-cost prescription drugs

Senators railed against pharmaceutical executives Tuesday for declining to testify before Congress about out-of-control drug prices, as lawmakers on both sides of the U.S. Capitol kicked off investigations sure to rattle one of the nation's most powerful industries.

30 Jan 2019

Scientists uncover new information about development of gastric cancer

Cardiff University researchers have uncovered new information about the underlying mechanisms for gastric cancer, providing hope of potential new therapies in the future.

29 Jan 2019

New class of antisense oligonucleotide therapeutics tested in humans

A first-in-human study with a new class of antisense oligonucleotide therapeutics showed the ability to target the RNA-silencing drug to the liver, resulting in improved potency and safety at therapeutic doses. The design and results of this trial, conducted in healthy human volunteers are reported in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.

28 Jan 2019

Cognetivity signs agreement to become ninth industry partner of Dementias Platform UK

Cognetivity Neurosciences Ltd. today announced that it has signed a commercial agreement with Dementias Platform UK to become its ninth industry partner.

25 Jan 2019

Combination of cystic fibrosis drugs found to be safe and effective in children aged 2-5 years

An open label Phase 3 study conducted at Ann & Robert H. Lurie Children's Hospital of Chicago and other centers established that a combination of cystic fibrosis drugs lumacaftor and ivacaftor is safe and effective in children aged 2-5 years, whose disease is caused by two copies of F508del-CFTR gene mutation - the most common and severe form of cystic fibrosis.

25 Jan 2019

Detecting Alzheimer’s in Hispanic patients may be more difficult than non-Hispanics

Researchers at Shiley-Marcos Alzheimer's Disease Research Center, part of University of California San Diego School of Medicine, report that autopsies of patients diagnosed with Alzheimer's disease when they were alive -- and confirmed by autopsy -- indicate many cognitive issues symptomatic of the condition are less noticeable in living Hispanic patients.

25 Jan 2019

Excessive suppression of GSK3 enzyme can trigger renal failure, finds study

Scientists have identified an enzyme that is a "master regulator" of kidney function that if excessively suppressed, can trigger renal failure. Their findings have implications for the use of existing drugs and the development of new pharmaceuticals.

24 Jan 2019

Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest results in modern and next-generation AI for Drug Discovery at the 3rd Annual SABPA FTD Forum in San Diego, California, 2 of February.

23 Jan 2019

County by county, researchers link opioid deaths to drugmakers’ marketing

Researchers sketched a vivid line Friday linking the dollars spent by drugmakers to woo doctors around the country to a vast opioid epidemic that has led to tens of thousands of deaths.

18 Jan 2019

New antibiotic discovery heralds breakthrough in the fight against drug-resistant bacteria

A new antibiotic developed by a Flinders University researcher is being heralded as a breakthrough in the war against a drug resistant superbug.

18 Jan 2019

Study: Over 5.6 million Americans exposed to high nitrate levels in drinking water

More than 5.6 million Americans are potentially exposed to nitrate in drinking water at levels that could cause health problems, according to a new study. In this first analysis of its kind, researchers found that water systems with higher nitrate levels also tend to serve communities with higher proportions of Hispanic residents.

18 Jan 2019

Ural Federal University scientists synthesize a group of multi-purpose fluorophores

A group of scientists from Russia's Ural Federal University, headed by Professor Grigory Zyryanov, synthesized a group of multi-purpose fluorophores.

18 Jan 2019

Podcast: KHN’s ‘What the Health?’ Drug prices are rising again. Is someone going to do something about it?

Many drugmakers have announced price increases with the start of the new year. The new Congress wants to do something about that. And even though both Republicans and Democrats want to address the politically potent issue of drug prices, it is unclear what they might be able to agree on.

17 Jan 2019

QIAGEN receives first companion diagnostic approval in Japan

QIAGEN N.V. today announced that the Japanese Pharmaceuticals and Medical Device Agency has approved the therascreen EGFR RGQ PCR Kit to allow its use as a companion diagnostic with Pfizer's VIZIMPRO (dacomitinib) for EGFR gene mutation-positive, inoperable or recurrent non-small cell lung cancer.

17 Jan 2019

Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli

Researchers from North Carolina State University have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli.

17 Jan 2019

FDA approves generic drug for treating focal seizures

The U.S. Food and Drug Administration approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizures, also called focal seizures, as an adjunctive therapy (given with another primary treatment) in patients 10 years and older who have responded inadequately to several alternative (refractory) treatments.

16 Jan 2019

Pharmaceuticals News and Research

Newron announces successful completion of patient enrollment in STARS study

Insilico to present its latest results in AI for Drug Discovery on CXOTalk Show

Podcast: KHN’s ‘What the Health?’ Live from D.C.: A look ahead at health policy in 2019

Expediting HPLC Method Development in Pharmaceutical Analysis

Congress wades into emotional debate over high-cost prescription drugs

Scientists uncover new information about development of gastric cancer

New class of antisense oligonucleotide therapeutics tested in humans

Cognetivity signs agreement to become ninth industry partner of Dementias Platform UK

Combination of cystic fibrosis drugs found to be safe and effective in children aged 2-5 years

Detecting Alzheimer’s in Hispanic patients may be more difficult than non-Hispanics

Excessive suppression of GSK3 enzyme can trigger renal failure, finds study

Insilico to present latest findings in AI for Drug Discovery at 3rd Annual SABPA FTD Forum

County by county, researchers link opioid deaths to drugmakers’ marketing

New antibiotic discovery heralds breakthrough in the fight against drug-resistant bacteria

Study: Over 5.6 million Americans exposed to high nitrate levels in drinking water

Ural Federal University scientists synthesize a group of multi-purpose fluorophores

Podcast: KHN’s ‘What the Health?’ Drug prices are rising again. Is someone going to do something about it?

QIAGEN receives first companion diagnostic approval in Japan

Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli

FDA approves generic drug for treating focal seizures

Industry Focus - Biopharma eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring